AMRN Q4 2017 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M+39.2% YoY

Gross Profit

$40M75.1% margin

Operating Income

-$7M-13.3% margin

Net Income

-$22M-41.7% margin

EPS (Diluted)

$-1.60

QoQ Revenue Growth

+13.7%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$162M

Total Liabilities

$227M

Stockholders' Equity

-$65M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$39M	+39.2%
Gross Profit	$40M	$29M	+41.7%
Operating Income	-$7M	-$13M	+44.4%
Net Income	-$22M	-$27M	+18.2%